Monday, 25 November 2013

Monday Science: Bodyguard Drugs for TB

Tuberculosis (TB) is notoriously difficult to treat, not least because the bacterium that causes it can hide inside macrophages - the very cells tasked with destroying invading infection. New research at Imperial College London has been approaching the problem from a biochemical angle, and may have come up with a way to design drugs that can guard the macrophage from invasion, exposing the disease to the active immune system.

Here's my interview with project leader Kurt Drickamer, my news article, and the original reference.

1 comment: